Ontology highlight
ABSTRACT: Microglia, the brain’s primary resident immune cells, can assume various phenotypes with diverse functional outcomes on brain homeostasis. In Alzheimer’s disease (AD), where microglia are a leading causal cell type, the identity of microglia subsets that drive neurodegeneration remains unresolved. Here, we discover that a conserved stress signaling pathway, the integrated stress response (ISR), characterizes a subset of microglia with neurodegenerative outcomes. ISR is activated in AD-associated microglia subsets, including the ultrastructurally distinct “dark” microglia linked to pathological synapse loss. Activation of ISR in microglia is sufficient to induce early features of dark microglia. In AD models, microglial ISR exacerbates neurodegenerative pathologies, such as Tau and synapse loss, while inhibiting microglial ISR ameliorates them. Mechanistically, we present evidence that ISR in microglia promotes the secretion of toxic long-chain lipids that impair neuron homeostasis and survival in vitro. Accordingly, pharmacological inhibition of ISR and lipid synthesis ameliorates synapse loss in AD models. Our results demonstrate that activation of ISR within microglia represents a pathway contributing to neurodegeneration and suggest that this may be sustained, at least in part, by the secretion of toxic long-chain lipids from ISR-activated microglia.
INSTRUMENT(S): Direct infusion MS - positive
PROVIDER: MTBLS11942 | MetaboLights | 2024-12-20
REPOSITORIES: MetaboLights
| Action | DRS | |||
|---|---|---|---|---|
| DMSO_1.mzML | Mzml | |||
| DMSO_2.mzML | Mzml | |||
| DMSO_3.mzML | Mzml | |||
| DMSO_4.mzML | Mzml | |||
| DMSO_5.mzML | Mzml |
Items per page: 5 1 - 5 of 32 |